pharmacies must stop selling compounded semaglutide π¨ FDA Moves to Permanently Shut Down GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these Compounding pharmacies to halt semaglutide
Description
Semaglutide Drugs, BNF

I would recommend this

GLP-1 Support is not meant to replicate prescription-level appetite suppression

If your healthcare provider failed to monitor you or a loved one for potential adverse effects associated with these drugs

The customers were never just obese people If the grey market only served people with severe obesity who couldnt wait for the FDA, this would be a simpler story about desperation and a slow approval pipeline

Roger H